Back to All Events

Matthew Nolan, PhD, who was awarded a Muscular Dystrophy Association and ALS Network Development Grant: “Developing novel chemical and genetic regulators of Stathmin-2 in ALS

Previous
Previous
August 22

Clotilde participates in the Neuronal TDP-43 Disease Staging Workshop in Miami

Next
Next
August 29

Sharon “Xunzhe” Yang MD joins from Peking Union Medical College Hospital as a visiting Associate Professor